Brenda Luken

Program Manager
Sanquinnovate

Presentation(s):

• OC 04.3 - N-glycan-mediated shielding of ADAMTS13 effectively prevents binding of pathogenic autoantibodies in high-titer patients with immune-mediated Thrombotic Thrombocytopenic Purpura

  Saturday, July 9, 2022
  1:30 PM – 1:45 PM